Literature DB >> 25545606

What is important in being cured from depression? Discordance between physicians and patients (1).

Koen Demyttenaere1, Anne-Françoise Donneau2, Adelin Albert2, Marc Ansseau3, Eric Constant4, Kees van Heeringen5.   

Abstract

AIMS: The comparison of what physicians and patients consider important in being cured from depression.
METHODS: 426 outpatients (in primary care and in psychiatric care) with a clinical diagnosis of major depression were included: at the start of antidepressant treatment, the importance of a range of items for being cured from depression (depressive, anxious and somatic symptoms, positive affect, functional impairment, quality of life) was assessed in physicians and patients separately and a ranking was made; after 3 months of treatment, the importance of these items for being cured from depression was re-assessed in the patients.
RESULTS: The items ranked top 10 by physicians mainly contain depressive symptoms while those ranked top 10 by patients mainly contain positive affect items and this attention to positive affect even increases at 3 months follow-up and is higher in patients with recurrent depression than in patients with a first episode of depression. Somatic symptoms consistently get the lowest ranking, as well in physicians as in patients.
CONCLUSIONS: Physicians differ significantly from patients in what they consider important for 'being cured from depression': physicians mainly focus on alleviation of depressive symptoms while patients mainly focus on the restoration of positive affect.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antidepressants; Depression; Expectations; Outcome

Mesh:

Substances:

Year:  2014        PMID: 25545606     DOI: 10.1016/j.jad.2014.12.004

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  21 in total

1.  Taking the depressed "person" into account before moving into personalized or precision medicine.

Authors:  Koen Demyttenaere
Journal:  World Psychiatry       Date:  2016-10       Impact factor: 49.548

2.  Predicting treatment outcome in depression: an introduction into current concepts and challenges.

Authors:  Nicolas Rost; Elisabeth B Binder; Tanja M Brückl
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-05-19       Impact factor: 5.270

3.  Levels of depressed mood and low interest for two years after response to cognitive therapy for recurrent depression.

Authors:  Jeffrey R Vittengl; Lee Anna Clark; Michael E Thase; Robin B Jarrett
Journal:  Behav Res Ther       Date:  2021-11-10

Review 4.  Toward a Better Understanding of the Mechanisms and Pathophysiology of Anhedonia: Are We Ready for Translation?

Authors:  Diego A Pizzagalli
Journal:  Am J Psychiatry       Date:  2022-07       Impact factor: 19.242

5.  In pursuit of full recovery in major depressive disorder.

Authors:  Vicent-Gil M; Serra-Blasco M; Navarra-Ventura G; Trujols J; Balanzá-Martínez V; Portella Mj; Cardoner N
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-09-09       Impact factor: 5.760

6.  The clinical characterization of the adult patient with depression aimed at personalization of management.

Authors:  Mario Maj; Dan J Stein; Gordon Parker; Mark Zimmerman; Giovanni A Fava; Marc De Hert; Koen Demyttenaere; Roger S McIntyre; Thomas Widiger; Hans-Ulrich Wittchen
Journal:  World Psychiatry       Date:  2020-10       Impact factor: 49.548

7.  What are the Relevant Outcomes of the Periodic Health Examination? A Comparison of Citizens' and Experts' Ratings.

Authors:  Isolde Sommer; Viktoria Titscher; Monika Szelag; Gerald Gartlehner
Journal:  Patient Prefer Adherence       Date:  2021-01-18       Impact factor: 2.711

8.  Modafinil Improves Episodic Memory and Working Memory Cognition in Patients With Remitted Depression: A Double-Blind, Randomized, Placebo-Controlled Study.

Authors:  Muzaffer Kaser; Julia B Deakin; Albert Michael; Camilo Zapata; Rachna Bansal; Dragana Ryan; Francesca Cormack; James B Rowe; Barbara J Sahakian
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2017-03

9.  Evaluating Augmented Depression Therapy (ADepT): study protocol for a pilot randomised controlled trial.

Authors:  Barnaby D Dunn; Emily Widnall; Nigel Reed; Rod Taylor; Christabel Owens; Anne Spencer; Gerda Kraag; Gerjo Kok; Nicole Geschwind; Kim Wright; Nicholas J Moberly; Michelle L Moulds; Andrew K MacLeod; Rachel Handley; David Richards; John Campbell; Willem Kuyken
Journal:  Pilot Feasibility Stud       Date:  2019-04-27

10.  Long-term follow-up on health-related quality of life in major depressive disorder: a 2-year European cohort study.

Authors:  Delphine Saragoussi; Michael Cronquist Christensen; Lene Hammer-Helmich; Benoît Rive; Maëlys Touya; Josep Maria Haro
Journal:  Neuropsychiatr Dis Treat       Date:  2018-05-22       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.